Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Duchenne Muscular Dystrophy

Published:2006-03-01 Issue:3 Volume:27 Page:83-88
ISSN:0191-9601
Container-title:Pediatrics In Review
language:en
Short-container-title:

Author:

Biggar W. Douglas¹

Affiliation:

1. Professor of Paediatrics, University of Toronto, Bloorview Macmillan Children’s Centre, Toronto, Ontario, Canada

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatricsinreview/article-pdf/27/3/83/993860/zpx00306000083.pdf

Reference8 articles.

1. Alman B, Raza N, Biggar WD. Deflazacort attenuates the progression of scoliosis in Duchenne muscular dystrophy. J Bone Joint Surg. 2004;86:519–524

2. Biggar WD, Gingras M, Fehlings D, Harris V, Steele C. Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr. 2001;138:45–50

3. Dubowitz V. Muscle Disorders in Childhood. London, England: Saunders; 1995:325–369

4. Hoffman EP. The muscular dystrophies. In: Rosenberg RN, ed. The Molecular and Genetic Basis of Neurological Disease. 2nd ed. Boston, Mass: Butterworth- Heineman; 1997:877–912

5. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. The Cochrane Database Systematic Reviews. 2005. Issue 4. Available at: http://www.cochrane.org/reviews/en/ab003725.html

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic mdx Mice;Antioxidants;2024-06-13

2. Evaluation of Quality of Life and Levels of Participation in Patients with Duchenne Muscular Dystrophy;Artuklu International Journal of Health Sciences;2023-12-22

3. Children with Duchenne muscular dystrophy display specific kinematic strategies during obstacle-crossing;Scientific Reports;2023-10-10

4. Development of a new instrument to evaluate gait characteristics of individuals with Duchenne Muscular Dystrophy: Gait Assessment Scale for Duchenne Muscular Dystrophy, and its validity and reliability;Early Human Development;2023-10

5. Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy;CPT: Pharmacometrics & Systems Pharmacology;2023-02-14